1. Home
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Clinical Trials Software Market - Global Outlook and Forecast 2022-2027

Clinical Trials Software Market - Global Outlook and Forecast 2022-2027

  • September 2022
  • 275 pages
  • ID: 6320983
  • Format: PDF
  • Arizton

Summary

Table of Contents

Search Inside

The global clinical trials software market is expected to grow at a CAGR of 15% during 2022-2027.

MARKET OVERVIEW

a) Clinical trials play an essential role in discovering new treatments for diseases and better ways to detect diseases, diagnose, and prevent the chance of developing the disease. The clinical trial process indicates what works for humans and what doesn’t by testing them on humans in a professional setup. The clinical trials software market growth is due to the increasing demand from pharmaceutical organizations to minimize the cost of medical research, reduce the burden, and increase access to advanced technologies.
b) Clinical trial software is also known as a clinical trial management system (CTMS). The software is used to manage research activities by the contract research organization (CROs). Increasing clinical trials worldwide drive the demand for new standard software solutions that enable easy access to activities for sponsors, CROs, medical device manufacturers, and outsourcing organizations engaged in medical research activities.
c) In global biopharmaceutical industries, there are significant changes addressed in the last decades, such as externalizing drugs research and development activities and manufacturing with the help of crucial strategies such as a partnership with small-medium size biopharma companies, academic institutes, government research institutes, and centers, etc. As a part of the significant changes in those industries, CROs became essential to clinical trial services. It helps speed up drug development processes and increase the manufacturing capabilities per the market’s needs. But the introduction of CTMS solved several challenges. It allowed the CROs and sponsors to overcome the restraint burden in clinical trials, from drug discovery to clinical trial phases and the approval cycle of drugs.
d) Recently, the COVID-19 crisis increased the digitalization of medical trials, and the adoption of digital tools and remote monitoring devices in the virtual clinical trial process has risen sharply. High focus on R&D activities, increasing demand for specialty medicines, and real-world evidence are some factors that led to the adoption of clinical trial management software solutions.
e) Remote clinical trial monitoring is the new standard for performing research in recent times. Clinical trials are a highly complex and expensive, and time-consuming process. So, with the increasing burden of medical research activities, most biopharma companies complete clinical trials with their in-house capabilities or by contract research organizations. So, vendors are adopting remote monitoring software due to the growing security purpose, well-established protocol, and ensuring that the research site conducts the clinical trials as per the protocol.
f) The COVID-19 pandemic has accelerated the ongoing shift toward remote monitoring through clinical trial management software solutions. It is one of the essential elements in the medical practice and is one of the most critical connections between CROs, sponsors, and the research site.
g) Cloud computing is a rapidly growing concept leveraging opportunities for market vendors. The shift from traditional methods such as paperwork to complete electronic tool applications will provide lucrative opportunities for market growth. The electronic data capture, transcribing data, Smart devices, and wearable solutions help directly collect data from patients without visiting the trial site. It helps collect data faster without disturbing patients’ daily life activities. It helps in the retention of patients. It reduced transportation and travel cost. Conversely, the growing craze for virtual research activities among the biopharma and medical device organizations will drive the demand for Clinical trials management software.
h) Due to insufficient recruitment and retention of participants in the study population, more than 80% of the research is failing, getting extended, and adding new study sites. Virtual clinical trials are witnessing growth due to increased patient enrolment through software solutions. In contrast, virtual patient recruitment software allows recruiting patients from across the globe, fulfills the demand, and increases the chances of success. It helps to eliminate the frequent traveling to study sites and do automation in medical data collection, increasing patient engagement, and retention.
i) Virtual collaboration strategies in medical research, using clinical trials management software, allow businesses to work rapidly and more efficiently, eliminate the need for document sharing to additional office locations, and reduce the burden.
j) Key players prefer the usage of unified platforms for conducting medical research. This provides multiple features that companies can use to conduct research. Medidata, a large clinical trials software provider, has one of the robust unified platforms most customers use.
k) As per the Clinical Trials Arena article 2022, IQVIA is one of the leading pharma companies in cloud computing. It shows that the filing of the companies in the pharmaceutical industry increased 12% between Q2 to Q3 in 2021.
l) One of the factors driving the market growth is the increasing complexity of clinical trial processes. Stringent regulation, the longer lifecycle of research, and high cost significantly increased the adoption of digital tools in tests to reduce the cost and timeline challenges.
m) During the pandemic COVID-19, most biopharma companies rapidly turned toward vaccine production. As well as running clinical trials were conducted using software solutions like remote monitoring and more.

MARKET SEGMENTATION
a) The market is segmented into on-enterprises and on-site segments. In 2021, the on-enterprises segment accounted for 78.75% market share and dominated the deployment segment. Due to increasing technology adoption in biopharmaceutical companies and rising usage of clinical trials management systems, on-enterprises deployment is in higher demand. On-site deployment delivers plenty of advantages to contract research organizations, sponsors, and academic and government institutes looking for new drug development. Biopharmaceutical companies have their own IT infrastructure, which helps them easily handle the CTMS solution for their research activities and reduces the cost as well as the timeline in patient data management, documentation, and scheduling of tasks. It is a one-time investment for organizations that delivers long-life services.
b) In 2021, the web-based delivery segment dominated the market with a 44.79% market share. Major biopharmaceuticals use web-based delivery. Web-based software is instantly changing the current landscape, such as data management, statistical analysis, medical writing, and regulatory submission. Their reviews are quickly done by the web-based clinical trials management software delivery methods. Increasing competitiveness in biopharma and contract research companies demands technology adoption and propelling the growth of software adoption. So, the delivery method through the web reduces the data entry and confusion between a broad range of data and helps direct data collection from participants through internet platforms. SaaS solutions have a lot of benefits that influence market growth. The rising acceptance of SaaS- (Software as a service) in CTMS is helping in faster delivery.
c) The global clinical trials software market is segmented into EDC, eCOA/ePRO, and eConsent. EDC is also referred to as electronic case report form (eCRF), which is vital software. Due to increasing medical research studies worldwide, data accuracy is becoming more critical. EDC is used to collect patient data and analyze the data produced during medical research studies. Increasing demand for patient participants and the rising use of EDC for data capturing drive the growth of the global clinical trials management system market. EDC dominated the global market with a share of 46.32% in 2021.
d) In 2021, CROs accounted for 45.95% of the clinical trials management system market share. The CRO organization experienced significant medical research demands from biopharmaceutical companies, medical device manufacturers, and other medical research authorities. Increasing competition in research development by biotech and pharmaceutical companies, high capital investment, and low success rate of clinical trials are some factors driving the demand for CROs.
e) North America is the leading clinical trials software market, with a market share of 34.03% in 2021. The clinical trials management system market size in North America was valued at USD 316.55 million in 2021. In North America, the presence of market players, a high number of biopharma companies, and research and development expenditure are the major factors propelling the market growth in the North American region.

Market Segments

Deployment
• On-enterprises
• On-Site

Delivery
• Web-based
• SaaS
• On-Premises

Feature
• EDC
• eCOA/ePRO
• eConsent

End-User
• CROs
• Bio-Pharmaceutical Companies
• Medical Device Manufacturer
• Others

Geography

North America
• US
• Canada
Europe
• UK
• France
• Germany
• Italy
• Spain
Asia Pacific(APAC)
• Japan
• China
• India
• South Korea
• Australia
Latin America
• Brazil
• Mexico
• Argentina
Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• South Africa

COMPETITION ANALYSIS

Increasing collaboration, rising adoption of cloud-based platforms, and new solution availabilities are factors that influence the high competition in the global clinical trial software market. Many regional clinical trial software companies also invest in the latest software products in Europe, APAC, and North America. Regional and local companies threaten global players due to their innovative and cost-effective products and technologies. This indicates that the market offers tremendous growth opportunities for existing and emerging players.

Every year number of new market players enter the market, which will positively influence the competition in the market.

Key Vendors
• BSI Business Systems Integration
• Clario
• Dassault Systemes
• IQVIA
• Labcorp Drug Development
• Oracle
• Paraxel

Other Prominent Vendors
• Advarra
• ArisGlobal
• AstraCOre
• Axiom Real-time Metirics
• Castor EDC
• ClinCapture
• DataTrial
• DataTrak
• IBM
• Florence Healthcare
• Fortress Medical
• Medrio
• Reify Health
• Signant Health
• SofPromed
• Statsols
• Veeva Systems (20)

KEY QUESTIONS ANSWERED
1. What was the global clinical trials management software market value in 2021?
2. How big is the clinical trials management system market?
3. Who are the key vendors in the clinical trials management systems market?
4. What are the factors driving the clinical trials management software market growth?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Clinical Trial Outsourcing Market - Competition Forecast and Opportunities, 2027

  • $ 4900
  • October 2022
  • 115 pages

Global Clinical Trial Outsourcing Market By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, ...

  • World
  • Clinical Trial
  • Industry analysis
  • Drug Approval

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on